Baolingbao BiologyLtd's high P/E ratio may not be justified ...
Baolingbao BiologyLtd's high P/E ratio may not be justified considering its recent earnings and market growth predictions. The company's three-year earnings trends aren't impacting its high P/E as expected, posing a risk to shareholders and potential investors.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000233719bee4b9bc.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment